World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR887
Date of registration: 18/01/2007
Primary sponsor: Nederlands instituut voor onderzoek van de gezondheidszorg (NIVEL)
Public title: RCT in breast cancer genetic counselling.
Scientific title: Web-based tailored information and question prompt for enhancing counselee participation and outcome; a RCT in breast cancer genetic counselling. - RCT in breast cancer genetic counselling
Date of first enrolment: 1/9/2007
Target sample size: 200
Recruitment status: complete
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=887
Study type:  intervention
Study design:  Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: 2 or more arms, randomized  
Countries of recruitment
The Netherlands
Contacts
Name: A.  Albada
Address:  NIVEL (Neterlands Institute for Health Services Research) Postbus 1568, Otterstraat 118-124 3500 BN Utrecht The Netherlands
Telephone: (+31) (0)30 272 97 00
Email: a.albada@nivel.nl
Affiliation: 
Name: S.   Dulmen, van
Address:  NIVEL (Neterlands Institute for Health Services Research) Postbus 1568, Otterstraat 118-124 3500 BN Utrecht The Netherlands
Telephone: (+31) (0)30 272 97 00
Email: s.vandulmen@nivel.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1.Counselee for breast cancer genetic counselling;

2. Age 18 or older;

3. Female gender;

4. Having internet access at home.

Exclusion criteria: 1. Age under 18;

2. Male gender;

3. Not having internet access at home.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Breast cancer, Genetic counseling, Web-based tailored , Communication

Intervention(s)
The information on the website (E-info geneca) is tailored to counselees' personal situation as guided by their answers on our previously developed 'QUOTE geneca' scale. This produces different packages of pre-visit information in content, extensiveness and complexity and may generate a variety of questions to be dealt with in the subsequent visit. E-info geneca will be developed by a multi-disciplinary team of genetic counsellors, psychologists, counselees and their relatives and using recent brochures of the Dutch Cancer Society.
Primary Outcome(s)
Counselees' participation, i.e. content and amount of questions asked and information received during the visit.
Secondary Outcome(s)
1. Realistic expectations;

2. Information recall;

3. Need fulfilment;

4. Satisfaction;

5. Pre-post changes in breast cancer knowledge;

6. Risk perception;

7. Personal control;

8. Cancer worry;

9. (Intended) adherence to screening advices or prophylactic surgery at 12 months;

10. Satisfaction with e-info gene;

11. Anxiety.
Secondary ID(s)
ISRCTN82643064
N/A
Source(s) of Monetary Support
Dutch Cancer Society
Secondary Sponsor(s)
University Medical Centre Utrecht (UMCU), Department of Medical Genetics
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history